We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$191M
AUM Growth
-$59.3M
Cap. Flow
-$76.2M
Cap. Flow %
-39.78%
Top 10 Hldgs %
5.8%
Holding
489
New
53
Increased
164
Reduced
226
Closed
46

Top Buys

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$888K
2
LEN icon
Lennar Class A
LEN
+$880K
3
MCHP icon
Microchip Technology
MCHP
+$860K
4
AME icon
Ametek
AME
+$859K
5
HD icon
Home Depot
HD
+$853K

Top Sells

Rank Stock Value
1
STLD icon
Steel Dynamics
STLD
+$1.62M
2
CQP icon
Cheniere Energy
CQP
+$1.53M
3
STOR
STORE Capital Corporation
STOR
+$1.44M
4
NOA
North American Construction
NOA
+$1.43M
5
STR
Sitio Royalties
STR
+$1.41M

Sector Composition

Rank Sector Weight
1 Healthcare 26.88%
2 Financials 12.6%
3 Technology 10.15%
4 Materials 9.55%
5 Real Estate 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMTX icon
401
Immatics
IMTX
$1.23B
$126K 0.07%
+14,500
New +$150K
ARCT icon
402
Arcturus Therapeutics
ARCT
$166M
$126K 0.07%
7,431
-661
-8% -$11.5K
NTLA icon
403
Intellia Therapeutics
NTLA
$1.55B
$126K 0.07%
3,610
+890
+33% +$42.3K
PMVP icon
404
PMV Pharmaceuticals
PMVP
$57.6M
$125K 0.07%
14,425
+3,364
+30% +$35.9K
AGEN
405
Agenus
AGEN
$285M
$125K 0.07%
2,653
-1,441
-35% -$73.3K
ERAS icon
406
Erasca
ERAS
$6.35B
$125K 0.07%
28,940
+7,453
+35% +$50.5K
ARQT icon
407
Arcutis Biotherapeutics
ARQT
$3.55B
$125K 0.07%
8,423
+3,148
+60% +$55K
PGEN icon
408
Precigen
PGEN
$2B
$125K 0.07%
81,912
-3,706
-4% -$6.37K
NRIX icon
409
Nurix Therapeutics
NRIX
$2.5B
$124K 0.07%
11,332
+519
+5% +$6.26K
CGEM icon
410
Cullinan Oncology
CGEM
$1.08B
$124K 0.06%
11,751
+3,065
+35% +$37.2K
BHVN icon
411
Biohaven
BHVN
$2.05B
$124K 0.06%
+8,916
New +$126K
AMRS
412
DELISTED
Amyris Inc.
AMRS
$122K 0.06%
79,585
+22,815
+40% +$50.9K
RCKT icon
413
Rocket Pharmaceuticals
RCKT
$343M
$120K 0.06%
6,154
-3,706
-38% -$68.2K
IGMS
414
DELISTED
IGM Biosciences
IGMS
$120K 0.06%
7,078
-241
-3% -$4.82K
ATAI icon
415
AtaiBeckley Inc
ATAI
$2.65B
$120K 0.06%
45,184
+12,843
+40% +$39K
ABUS icon
416
Arbutus Biopharma
ABUS
$861M
$120K 0.06%
51,496
+8,508
+20% +$20.4K
EDIT icon
417
Editas Medicine
EDIT
$402M
$120K 0.06%
13,520
+3,080
+30% +$33.8K
VERV
418
DELISTED
Verve Therapeutics
VERV
$120K 0.06%
+6,195
New +$164K
RLAY icon
419
Relay Therapeutics
RLAY
$4.13B
$120K 0.06%
8,004
+478
+6% +$9.15K
ATRA icon
420
Atara Biotherapeutics
ATRA
$73.7M
$118K 0.06%
1,444
+634
+78% +$66.1K
RXRX icon
421
Recursion Pharmaceuticals
RXRX
$1.62B
$118K 0.06%
15,342
-1,505
-9% -$14.8K
KYMR icon
422
Kymera Therapeutics
KYMR
$8.82B
$118K 0.06%
4,729
-2,493
-35% -$66.5K
CVAC
423
DELISTED
CureVac
CVAC
$118K 0.06%
19,535
+11,802
+153% +$87.2K
ACET icon
424
Adicet Bio
ACET
$77.6M
$118K 0.06%
823
+245
+42% +$61.1K
DYN icon
425
Dyne Therapeutics
DYN
$4.23B
$118K 0.06%
+10,150
New +$117K
15 16
17
18 19

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, Virtus ETF Advisers held 489 positions worth $191M, down 24% from $251M the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Virtus ETF Advisers withdrew a net $76.2M in Q4 2022, closing 46 positions and reducing 226 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $877K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Financials and Technology.

Against the trend, Virtus ETF Advisers opened a new position in D.R. Horton worth $987K.

  • Virtus ETF Advisers's largest Q4 2022 buy was D.R. Horton: 11,078 shares worth $987K.
  • Virtus ETF Advisers added most to Qualcomm in Q4 2022, an estimated $271K increase.
  • Virtus ETF Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $1.62M.
  • Virtus ETF Advisers fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2022, selling an estimated $877K.
  • Virtus ETF Advisers's ten largest holdings make up 5.8% of its $191M portfolio in Q4 2022.
  • Virtus ETF Advisers opened 53 new positions and closed 46 in Q4 2022.
  • Virtus ETF Advisers's portfolio value fell 24% quarter-over-quarter to $191M.

Based on Virtus ETF Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.